A detailed history of Harvest Portfolios Group Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Harvest Portfolios Group Inc. holds 279,324 shares of LLY stock, worth $285 Million. This represents 4.02% of its overall portfolio holdings.

Number of Shares
279,324
Previous 161,867 72.56%
Holding current value
$285 Million
Previous $126 Million 68.9%
% of portfolio
4.02%
Previous 2.98%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

BUY
$625.65 - $812.69 $73.5 Million - $95.5 Million
117,457 Added 72.56%
279,324 $213 Million
Q2 2025

Aug 06, 2025

BUY
$713.71 - $898.95 $25.5 Million - $32.1 Million
35,712 Added 28.31%
161,867 $126 Million
Q1 2025

May 14, 2025

BUY
$725.72 - $929.72 $2.37 Million - $3.03 Million
3,263 Added 2.66%
126,155 $104 Million
Q4 2024

Feb 14, 2025

BUY
$727.2 - $932.06 $26.6 Million - $34.1 Million
36,587 Added 42.39%
122,892 $94.9 Million
Q3 2024

Oct 30, 2024

BUY
$772.14 - $960.02 $15.6 Million - $19.3 Million
20,146 Added 30.45%
86,305 $76.5 Million
Q2 2024

Aug 13, 2024

SELL
$724.87 - $909.04 $658,181 - $825,408
-908 Reduced 1.35%
66,159 $59.9 Million
Q1 2024

May 14, 2024

SELL
$592.2 - $792.28 $15.6 Million - $20.8 Million
-26,289 Reduced 28.16%
67,067 $52.2 Million
Q4 2023

Feb 14, 2024

SELL
$525.19 - $619.13 $1.37 Million - $1.61 Million
-2,600 Reduced 2.71%
93,356 $54.4 Million
Q3 2023

Nov 14, 2023

SELL
$434.7 - $599.3 $7.27 Million - $10 Million
-16,719 Reduced 14.84%
95,956 $51.5 Million
Q2 2023

Aug 14, 2023

SELL
$350.74 - $468.98 $15.7 Million - $21 Million
-44,842 Reduced 28.47%
112,675 $52.8 Million
Q1 2023

May 18, 2023

BUY
$310.63 - $364.82 $9.62 Million - $11.3 Million
30,969 Added 24.47%
157,517 $54.1 Million
Q4 2022

Feb 14, 2023

BUY
$321.55 - $374.67 $40.7 Million - $47.4 Million
126,548 New
126,548 $0

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Harvest Portfolios Group Inc. Portfolio

Follow Harvest Portfolios Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harvest Portfolios Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harvest Portfolios Group Inc. with notifications on news.